Israel Englander Bio Line Rx Ltd. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLRX
# of Institutions
37Shares Held
3.95MCall Options Held
46.5KPut Options Held
6.3K-
Highbridge Capital Management LLC New York, NY1.01MShares$3.75 Million0.05% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$3.03 Million4.05% of portfolio
-
Values First Advisors, Inc.166KShares$617,5250.02% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$583,2670.37% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY94.1KShares$349,2330.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $228M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...